Darvish Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 23-12-2024
- Paid Up Capital ₹ 0.90 M
as on 23-12-2024
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2019
- Revenue -28.23%
(FY 2019)
- Profit -54.38%
(FY 2019)
- Ebitda -1199.71%
(FY 2019)
- Net Worth -353.26%
(FY 2019)
- Total Assets 14.80%
(FY 2019)
About Darvish Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Vishal Gandhi, Darshan Vyas, and Mehulkumar Radadiya serve as directors at the Company.
- CIN/LLPIN
U33100AS2017PTC017723
- Company No.
017723
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2017
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Kamrup, Assam, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Darvish Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Gandhi  | Director | 19-Jan-2017 | Current |
| Darshan Vyas | Director | 19-Jan-2017 | Current |
| Mehulkumar Radadiya | Director | 11-Feb-2019 | Current |
Financial Performance of Darvish Pharma.
Darvish Pharma Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 28.23% decrease. The company also saw a substantial fall in profitability, with a 54.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 353.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Darvish Pharma?
In 2019, Darvish Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Darvish Pharma?
Darvish Pharma has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Darvish Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Darvish Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
